Trending intel short linkNo signup · Email subscription
30.6k following · GLP-1 / Eli Lilly / FDA

FDA approval timeline for Eli Lilly's Orforglipron diabetes indication

Follow the FDA approval progress and result announcement schedule changes for Eli Lilly's oral small molecule GLP-1 Orforglipron in type 2 diabetes indication.

30.6k following135.8k views
By clicking “Confirm”, you acknowledge that you have read and agree to
/ /
Unlimited Free Public IntelligenceOnly key changes trigger emailsUnsubscribe anytime
Monitor official signalsTrack announcements, filings, company statements, prices, and investor updates.
AI summaryFilter repeated noise and provide concise conclusions with source confidence.
Notify only when usefulNo daily spam. You only get emailed when meaningful progress appears.